COVID IMPACT: PHARMA SEES DECLINE OF 12% IN APRIL

Highlights

• Manufacturing at pharmaceutical units continues to be impacted courtesy of lockdown-driven disruption

• All the pharmaceutical companies are facing challenges in distribution, manufacturing and logistics

• Industry experts have predicted growth of 1-5 percent in the domestic retail market

The domestic pharma retail market has witnessed one of the sharpest falls in three years ....